The uptake and metabolism of radioactive ADP, AMP and adenosine was investigated in the pulmonary circulation of lungs taken from rats with streptozotocin-induced diabetes. Between 0.26 and 500 ~tmol/1 ADP was extensively hydrolysed to AMP equally,in control and diabetic lungs. At 1 mmol/1 there was less ADP breakdown in diabetic lungs. Hydrolysis of AMP to adenosine was also less in diabetic lungs at 10 ~tmol/1 and 1 mmol/1 substrate concentration, but adenosine metabolism and uptake at these concentrations was not affected by diabetes. The results indicate that formation of the anti-aggregatory adenosine and, to a lesser extent, breakdown of the pro-aggregatory ADP were decreased in diabetic lungs and may contribute to the platelet hyperreactivity associated with diabetes.
Infusion of Radiolabelled Substrates
After an initial 10-min period of perfusion to clear the lung of blood and to allow for equilibration, radiolabelled 14C or 3H-ADP, AMP or adenosine (0.665 lxCi of 14C or 6.65 ~tCi of 3H per infusion) together with varying amounts of unlabelled substrate were infused at a rate of 0.8 ml/min for 10 s through the pulmonary arterial cannula. Lung effluent was collected during and after this infusion either to measure total radioactivity (efflux) or for analysis by thin layer chromatography as described below.
Efflux of Radioactivity
In these experiments lung effluent was collected in 15 s fractions for the first 2 min. Samples (1 ml) of each fraction were mixed with 10 ml Triton-toluene scintillant (25g PPO+1.25g dimethyl POPOP+5 litres toluene+2.5 litres Triton X-t00) and the radioactivity measured. Fig. i . Efflux of radioactivity from isolated rat lung following infusion of 14C-ADP (10 llmol/]; solid lines) or 3H adenosine (10 p.mol/l; broken lines). The infusion period (10 s) is marked by the black bar. For either substrate, efflux from control lungs (O) was not different from that from diabetic lungs ([]), although the efflux of 14C (from ADP) was faster than that of 3H (from adenosine). The values shown are the mean results (n =3, ADP; n =2, adenosine) of the radioactivity (as disintegrations/min: DPM) per ml of effluent collected in 15 s fractions
Analysis of Lung Effluent
Lung effluent was collected in a single (60 s) fraction during and after the infusion of radiolabelled substrate. The 60 s effluent fraction was acidified to pH 3.5 with 10% HC104 and aliquots (20 ~d) applied to plastic-backed silica gel plates containing a fuorescent indicator for analysis by thin layer chromatography. A mixture of marker ATP, ADP, AMP, inosine monophosphate (IMP), inosine, adenosine, hypoxanthine and adenine, was applied to the plates which were developed in one of two solvent systems. System I was isobutyl alcohol/amyl alcohol/ethylene glycol monoethyl ether/ammonia/water, 45 7:4: 3 : 4 [13] . In this solvent system the nucleotides ATP, ADP, AMP and IMP remained at or near the origin while the nucleosides were better resolved with typical Rf values (for 14 cm solvent front height) of: inosine, 0.26; hypoxanthine, 0.46; adenosine, 0.57; adenine, 0.64. All samples were analysed in both solvent systems unless otherwise stated.
Standards were visualised under ultraviolet light and quenched purine areas were marked, cut out and transferred to scintillation vials. The purines were eluted with distilled water (1 ml) for 1 h, Triton-toluene scintillant (10 ml) was added and the radioactivity counted in a liquid scintillation counter. Over 90% of the radioactivity applied was recovered from the plates.
Lung uptake: Immediately following substrate infusion and effluent collection, lungs were taken down from the perfusion system, dissected free of the trachea, the remainder of the heart and any extraneous tissue, weighed and homogenised in cold 10% (w/v) trichloroacetic acid (lung weight to volume ratio, 1 : 10). The homogenate was centrifuged at 1,000 x g for 20 rain and the radioactivity counted in aliquots of the supernatant (20 lxl). Lung supernatants from adenosine experiments were adjusted to pH 5.5 with 5 mol/1-KzCO3 and samples (20 lxl) analysed by thin layer chromatography as described above. To check for breakdown of substrate during the extraction process, 3H-ADP, -AMP, -ATP and -adenosine were added separately to perfused lungs immediately before homogenisation in trichloroacetic acid and the extraction and analysis carried out as usual. The tested compounds were stable during this procedure, > 93% of each remaining as unchanged substrate after extraction and analysis.
Incubation of ADP with Lung Effluent
Samples of lung effluent were collected after the initial 10-rain period of perfusion. Lung effluent (1 ml) was incubated with 3H-ADP (100 l-tl, 0.5 ~tCi, final concentration of 10 p.mol/1 or 1 mmol/1) in a shaking water bath at 37 ~ Aliquots (200 ~1) were taken immediately on addition of the substrate and at hourly intervals for up to 4 h. Each aliquot was adjusted to pH 3.5 with cold HC104 (2.5%) before analysis by thin layer chromatography in solvent I as described above. Protein in the effluents was estimated by the method described by Mejbaum-Katzenellenbogen and Dohryszycka [9] .
Materials
Sodium pentobarbitone (Sagatal) was purchased from May & Baker, Dagenham, UK. The following compounds were purchased from Sigma, Poole, UK: streptozotocin; diagnostic kit for blood glucose deter- alysed at the times shown by thin layer chromatography using solvent system I.
Where no value is given < 1% of total radioactivity was associated with that component 
Results

Breakdown of ADP
Following infusions of radioactive ADP, the majority of the radioactivity was recovered in lung effluent very rapidly. By 1 rain, the radioactivity had fallen to -1% of its peak value in lungs from control rats and this effiux was not different in lungs from diabetic rats (Fig. 1) . Although the proportion of infused radioactivity in the standard I rain collection period ( Table 1 , the major product was AMP, always comprising > 80% of the effluent radioactivity from either control or diabetic lungs. The only other major metabolite was adenosine and its formation was always less in diabetic than in control lungs ( Table 1) In a previous unpublished study, we have shown nucleotidase activity to be present in lung effluent itself, i. e. in perfusate which had passed through the lung. We therefore incubated, for up to 4 h, two concentrations of ADP (10 ~tmol/1 and i mmol/1) with effluent collected from control and diabetic lungs and analysed the incubation mixture at hourly intervals. As shown in Table 2 , at the lower concentration, the proportions of ADP and AMP in the two sets of incubations were similar over the 4-h period. However, there was relatively less adenosine in the incubation mixture from diabetic lung ef- Results are expressed as mean + SEM of the corresponding number of lungs shown in parentheses Table 5 . Analysis of radioactivity retained in lung 1 min after infusion of 3H-adenosine (10 p, mol/1) in control and diabetic rats Results are expressed as mean_+ SEM of the number of lungs shown in parentheses creasing concentration from 10 ~Lmo1/1 to 1 mmol/1, this effect was observed equally in control and diabetic lungs. The distribution of effluent radioactivity between the different metabolites was similar in both sets of lungs, unchanged adenosine comprising the major proportion, about one-third at 10 gmol/1 and almost threequarters at 1 mmol/1. Radioactivity retained by lung (Table 5 ) was also similarly distributed in both sets of lungs, predominantly as ATP. This analysis was performed only after the 10 ~tmol/1 infusion of adenosine as the amount of radioactivity retained in lung after 1 mmol/1 adenosine was too low.
fluent than in the control incubation at all times. At the higher substrate concentration (1 mmol/1) there was a marked increase in ADP survival in diabetic lung effluent compared with control lung effluent and this was accompanied by a decrease in AMP content. No measurable amounts (i. e. < 1% of the total radioactivity) of adenosine were found at the higher concentration in either control or diabetic lung effluent samples. The protein content of control lung effluent (82 _+ 22 ~tg/ml) was not significantly different from that of effluent from diabetic lungs (68 _+ 28 gg/ml).
Breakdown of AMP
Using infusions of AMP, we confirmed directly the high survival of this nucleotide on passage through the pulmonary circulations and were able to demonstrate greater survival, at 10 lxmol/l and 1 mmol/1 in diabetic lungs (Table 3 ). This greater survival of substrate was accompanied by decreases in adenosine formation and, at 1 mmol/1, also in the formation of hypoxanthine.
Adenosine Metabolism
Although the appearance of radioactivity in lung effluent following infusion of 3H-adenosine was slower than that after ADP infusions, this efflux of radioactivity was not altered in lungs from diabetic rats (Fig. 1) . Analysis of effluent radioactivity (Table 4) showed that although the proportion in the 1 rain fraction increased with in-
Discussion
We set out to investigate the effect of diabetes on the fate of adenine nucleotides and adenosine in the pulmonary circulation of rat lungs, because the ADP-ase activity of vascular endothelium could be a component of the endothelial anti-aggregatory system [8] and a hyper-aggregable state is well recognized in diabetes [3] . There are, in fact, at least three ways in which endothelium could modify platelet behaviour, which are rele-9 vant here. Firstly, the breakdown and, thus, inactivation of pro-aggregatory ADP released from aggregating platelets; secondly, the formation, by hydrolysis of AMP produced via ADP-ase, of anti-aggregatory adenosine, and thirdly, the removal of adenosine by uptake into endothelium [4, 5, 11, 12] . The first two reactions would have anti-aggregatory effects and the third, by diminishing the anti-aggregatory factors in the vascular space, a pro-aggregatory effect. Thus, to produce the maximal increase of pro-aggregatory factors, we might expect a decrease in ADP-ase and AMP-ase activities and an increase in adenosine uptake. We observed a decrease in ADP-ase activity only at the highest concentration (1 mmol/1), where survival of ADP was doubled in diabetic lungs compared with that in control lungs. This high concentration of substrate is unlikely to be encountered in blood even in pathological conditions. It is nevertheless worth pointing out that in the micro-environment of platelets aggregating close to the endothelium, higher concentrations might be attained than those in the bulk flow of blood. The relative lack of ADP-ase in diabetic lungs was more obvious in the experiments carried out with lung effluent.
With regard to AMP-ase activity, rat perfused lung was relatively deficient in this enzyme as shown by the very high survival of AMP either when produced from ADP or given directly. In spite of this deficiency, the breakdown of AMP in lungs from diabetic rats was always lower than in controls, less adenosine being formed either from ADP or from AMP. This effect was observed at concentrations < 1 mmol/1 and would thus be more likely to be of importance in vivo. It is relevant to note that in human isolated lung, AMP-ase activity is much higher, survival of AMP being only 12% [2] and thus a decreased AMP-ase activity in lungs of diabetic patients might play a proportionately larger role in controlling platelet function.
We have used the perfused lung in our studies, not because pulmonary thrombosis is particularly associated with diabetes, but because the pulmonary circulation offers a convenient preparation of vascular endothelium to study in situ. Two of the endothelium's enzymic activities, ADP-ase and AMP-ase [5, 12] were decreased in diabetic lungs. This decrease could be due to a lack of enzymic activity, i. e. altered cell membrane or to a lack of endothelium, i. e. less cells. We favour the former explanation as neither adenosine uptake (Table 5 ) nor the metabolism of 5-hydroxytryptamine, another endothelial cell activity [14] , was decreased in streptozotocintreated animals (Bakhle and Chelliah, unpublished data) . Furthermore, no immediate cytotoxic effect of streptozotocin on ADP metabolism was observed in lungs 6-8 h after treatment.
Although the magnitude of the change induced by diabetes is small, it is a change in the direction predicted and compatible with the changes in platelet behaviour [3] . This result taken together with the reduction in prostacyclin synthesis in diabetic lung [15] and other tissues [6] suggests that the hyper-aggregable state associated with diabetes is not solely due to hyper-reactivity of platelets [7] but also reflects a loss of the normal antiaggregatory properties of endothelium. Such a conclusion would emphasise that the biochemical properties of the blood vessel wall are essential components of the factors controlling platelet behaviour in diabetes,
